SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
EPIGENOMICS AG
(NQPK:EPGNF Last Sale: 4.37 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (EPGNF : $4.37)
$52 million Market Cap at September 11, 2013
Medical Products SubIndustry up .00% / Health Industry up .00% Today
Berlin, Research Report Earnings Snapshot - Last
Germany Annual Reports


Molecular diagnostics company developing and commercializing a pipeline of proprietary products for the screening and diagnosis of cancer. Products enable doctors to diagnose cancer earlier and more accurately, leading to improved outcomes for patients. Lead product, Epi proColon®, is a blood-based test for the early detection of colorectal cancer, which is currently marketed in Europe and is in development for the USA.
Historical Charts    Technical Analysis
No Historical Data available for EPGNF

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common EPGNF $4.37 $ 0 $4.37 $4.37 6,000 $1.11 $4.75 11,967
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $52,296

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex